A role for uric acid in the progression of renal disease.

PubWeight™: 3.77‹?› | Rank: Top 1%

🔗 View Article (PMID 12444207)

Published in J Am Soc Nephrol on December 01, 2002

Authors

Duk-Hee Kang1, Takahiko Nakagawa, Lili Feng, Susumu Watanabe, Lin Han, Marilda Mazzali, Luan Truong, Raymond Harris, Richard J Johnson

Author Affiliations

1: Division of Nephrology, Baylor College of Medicine, Houston, Texas, USA. dhkang@ewha.ac.kr

Associated clinical trials:

Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation | NCT04017806

Articles citing this

(truncated to the top 100)

Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20

Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05

Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol (2008) 3.42

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65

Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44

Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum (2009) 2.07

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol (2008) 1.93

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.74

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol (2009) 1.69

The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med (2008) 1.65

Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63

Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care (2013) 1.62

The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant (2010) 1.60

Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant (2013) 1.55

Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study. Am J Hypertens (2014) 1.48

Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant (2010) 1.45

Influence of urate-lowering therapies on renal handling of uric acid. Clin Rheumatol (2014) 1.44

Uric acid as a pathogenic factor in preeclampsia. Placenta (2008) 1.38

Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol (2009) 1.38

Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci (2007) 1.33

Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32

Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol (2005) 1.27

Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care (2011) 1.23

Uric acid as a target of therapy in CKD. Am J Kidney Dis (2012) 1.22

Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med (2009) 1.21

Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep (2013) 1.20

Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol (2008) 1.20

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol (2014) 1.19

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol (2013) 1.15

Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med (2010) 1.13

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci (2011) 1.12

Uric acid as a mediator of diabetic nephropathy. Semin Nephrol (2011) 1.11

A within-patient analysis for time-varying risk factors of CKD progression. J Am Soc Nephrol (2013) 1.11

Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One (2011) 1.11

Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res (2011) 1.10

Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One (2010) 1.09

Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09

Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Transl Med (2012) 1.08

Fructose and vitamin C intake do not influence risk for developing hypertension. J Am Soc Nephrol (2009) 1.08

Association between Related Purine Metabolites and Diabetic Retinopathy in Type 2 Diabetic Patients. Int J Endocrinol (2014) 1.02

Plasmodium-induced inflammation by uric acid. PLoS Pathog (2008) 0.99

Distinct roles for basal and induced COX-2 in podocyte injury. J Am Soc Nephrol (2009) 0.98

Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers. Environ Health Perspect (2005) 0.98

Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol (2009) 0.97

Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med (2013) 0.95

Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens (2008) 0.95

Partial hypoxanthine-guanine phosphoribosyltransferase deficiency presenting as acute renal failure. Pediatr Nephrol (2005) 0.95

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol (2015) 0.94

Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney Int (2007) 0.94

Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids (2009) 0.94

The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease. Med Hypotheses (2008) 0.94

Gq-dependent signaling upregulates COX2 in glomerular podocytes. J Am Soc Nephrol (2008) 0.93

Prevention of obesity-induced renal injury in male mice by DPP4 inhibition. Endocrinology (2014) 0.93

Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats. Am J Physiol Renal Physiol (2013) 0.93

Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol (2011) 0.92

Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci (2013) 0.92

Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens (2009) 0.92

Renal effects of dapagliflozin in patients with type 2 diabetes. Ther Adv Endocrinol Metab (2014) 0.91

Serum Uric Acid and Risk of CKD in Type 2 Diabetes. Clin J Am Soc Nephrol (2015) 0.90

Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy. Adv Ther (2015) 0.90

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant (2012) 0.89

Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis (2010) 0.89

The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. Trials (2014) 0.89

Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol (2011) 0.88

Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010. Semin Arthritis Rheum (2013) 0.88

The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship. Biomed Res Int (2014) 0.88

Artificial cold air increases the cardiovascular risks in spontaneously hypertensive rats. Int J Environ Res Public Health (2012) 0.88

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review. Nephrourol Mon (2015) 0.87

Soft coral-derived lemnalol alleviates monosodium urate-induced gouty arthritis in rats by inhibiting leukocyte infiltration and iNOS, COX-2 and c-Fos protein expression. Mar Drugs (2013) 0.86

The association between blood pressure level and serum uric acid concentration in hemodialysis patients. J Nephropathol (2015) 0.86

Serum uric acid and chronic kidney disease: the role of hypertension. PLoS One (2013) 0.86

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis. Front Cell Neurosci (2013) 0.86

Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study. Cardiovasc J Afr (2012) 0.85

Uric acid, CKD, and cardiovascular disease: confounders, culprits, and circles. Am J Kidney Dis (2010) 0.85

Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses (2010) 0.84

Metabolic control of renin secretion. Pflugers Arch (2012) 0.83

Allopurinol for prevention of progression of kidney disease with hyperuricemia. Indian J Nephrol (2013) 0.82

Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagn Res (2014) 0.81

Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. J Clin Hypertens (Greenwich) (2012) 0.81

Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am (2014) 0.81

Diabetes: Lowering serum uric acid levels to prevent kidney failure. Nat Rev Nephrol (2011) 0.81

Increased xanthine oxidase in the skin of preeclamptic women. Reprod Sci (2009) 0.81

Use of uric acid-lowering agents limits experimental cyclosporine nephropathy. Nephron Exp Nephrol (2011) 0.81

Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population. PLoS One (2015) 0.80

Incidence of Severe Malaria Syndromes and Status of Immune Responses among Khat Chewer Malaria Patients in Ethiopia. PLoS One (2015) 0.80

The association between hyperuricemia and betel nut chewing in Taiwanese men: a cross-sectional study. BMC Public Health (2013) 0.80

Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan. PLoS One (2013) 0.80

Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol (2011) 0.80

Heat stress, hydration and uric acid: a cross-sectional study in workers of three occupations in a hotspot of Mesoamerican nephropathy in Nicaragua. BMJ Open (2016) 0.80

Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. Cardiol Res Pract (2011) 0.80

Uric acid and thiocyanate as competing substrates of lactoperoxidase. J Biol Chem (2014) 0.80

Association of renal manifestations with serum uric acid in Korean adults with normal uric acid levels. J Korean Med Sci (2010) 0.80

Asymptomatic hyperuricemia: is it time to intervene? Clin Rheumatol (2017) 0.79

Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 0.79

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout. Core Evid (2010) 0.79

Clinical epidemiology of reduced kidney function among elderly male fishing and agricultural population in Taipei, Taiwan. Biomed Res Int (2013) 0.79

Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease? Kidney Res Clin Pract (2012) 0.78

Uromodulin: old friend with new roles in health and disease. Pediatr Nephrol (2013) 0.78

Articles by these authors

Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20

Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98

T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation (2007) 6.23

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA (2008) 5.59

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (2003) 5.47

Hyperuricemia induces endothelial dysfunction. Kidney Int (2005) 5.36

Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr (2007) 5.28

A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2005) 4.95

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology (2010) 3.73

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol (2005) 3.73

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension (2003) 3.39

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37

Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol (2008) 3.33

Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol (2007) 3.08

Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol (2002) 2.83

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78

Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol (2007) 2.71

Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol (2009) 2.70

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65

A strict low protein diet during the predialysis period suppresses peritoneal permeability at induction of peritoneal dialysis. Perit Dial Int (2009) 2.58

Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol (2002) 2.51

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int (2010) 2.47

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47

Hyperuricemia in childhood primary hypertension. Hypertension (2003) 2.39

Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J Clin Hypertens (Greenwich) (2012) 2.37

Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem (2004) 2.36

Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun (2013) 2.29

Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol (2008) 2.28

Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol (2005) 2.24

Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol (2007) 2.24

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol (2003) 2.24

Biological consequences of tightly bent DNA: the other life of a macromolecular celebrity. Biopolymers (2007) 2.19

Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes (2013) 2.03

Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension (2006) 2.02

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int (2005) 2.02

Increased fructose associates with elevated blood pressure. J Am Soc Nephrol (2010) 2.01

TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int (2004) 1.95

Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol (2006) 1.94

Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J (2003) 1.93

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol (2002) 1.89

J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis (2006) 1.88

Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol (2002) 1.86

Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol (2003) 1.84

Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol (2006) 1.83

CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol (2013) 1.83

Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes (2011) 1.82

Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med (2006) 1.81

Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens (2010) 1.80

Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids (2008) 1.76

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes (2009) 1.76

Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol (2004) 1.76

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2007) 1.74

Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A (2012) 1.72

Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol (2008) 1.72

Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis (2007) 1.71

Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens (2004) 1.71

Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol (2008) 1.69

Molecular physiology of urate transport. Physiology (Bethesda) (2005) 1.69

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol (2009) 1.69

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med (2009) 1.68

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol (2008) 1.68

Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol (2003) 1.68

Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem (2012) 1.67

Surgical treatment of multivalvular endocarditis: twenty-one-year single center experience. J Thorac Cardiovasc Surg (2009) 1.66

The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med (2008) 1.65

Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant (2010) 1.65

Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol (2007) 1.65

Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol (2002) 1.64

Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63

Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol Ther (2009) 1.60

Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids (2008) 1.59

The role of uric acid in the pathogenesis of human cardiovascular disease. Heart (2013) 1.59

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care (2013) 1.58

Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. J Am Soc Nephrol (2008) 1.57

Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl (2003) 1.57